27(top 5%)
papers
860(top 5%)
citations
11(top 5%)
h-index
23(top 5%)
g-index
30
all documents
998
doc citations
440
citing journals

Top Articles

#TitleJournalYearCitations
1TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cellsLife Science Alliance2020643
2Lipoxin and resolvin biosynthesis is dependent on 5‐lipoxygenase activating proteinFASEB Journal201573
3Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 MacrodomainACS Medicinal Chemistry Letters202135
4l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγJournal of Medicinal Chemistry202031
5Demonstrating Ligandability of the LC3A and LC3B Adapter InterfaceJournal of Medicinal Chemistry202125
6Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase DomainJournal of Medicinal Chemistry201921
7Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418Biochemical Pharmacology201719
8Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγJournal of Biological Chemistry202117
9Chiral chromatography–tandem mass spectrometry applied to the determination of pro-resolving lipid mediatorsJournal of Chromatography A201416
10Exploring CYP2J2: lipid mediators, inhibitors and therapeutic implicationsDrug Discovery Today202014
11Design, Synthesis, and Structure–Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-LipoxygenaseJournal of Medicinal Chemistry202013
12First Structure–Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing PromotersJournal of Medicinal Chemistry202012
13Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase InhibitorsJournal of Medicinal Chemistry202110
14Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ ModulationJournal of the American Chemical Society202310
15Computer-Aided Selective Optimization of Side Activities of TalinololACS Medicinal Chemistry Letters20199
16Systematic Assessment of Fragment Identification for Multitarget Drug DesignChemMedChem20219
17Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ ModulatorJournal of Medicinal Chemistry20218
18Photosensitization enables Pauson-Khand–type reactions with nitrenesScience20248
19AGMO Inhibitor Reduces 3T3-L1 AdipogenesisCells20216
20Structure optimization of a new class of PPARγ antagonistsBioorganic and Medicinal Chemistry20195
21Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual ScreeningACS Medicinal Chemistry Letters20215
22Phenolate‐Induced N−O Bond Formation versus Tiemann‐Type Rearrangement for the Synthesis of 3‐Aminobenzisoxazoles and 2‐AminobenzoxazolesChemistryOpen20224
23Development and Characterization of a Fluorescent Ligand for Leukotriene B4 Receptor 2 in Cells and TissuesJournal of Medicinal Chemistry20223
24Photochemistry in Medicinal Chemistry and Chemical BiologyJournal of Medicinal Chemistry20242
25Discovery of a Small Molecule Activator of Slack (Kcnt1) Potassium Channels That Significantly Reduces Scratching in Mouse Models of Histamine‐Independent and Chronic ItchAdvanced Science20240
26Development of a Potent and Selective G2A (GPR132) AgonistJournal of Medicinal Chemistry00
27A C-Degron Structure-Based Approach for the Development of Ligands Targeting the E3 Ligase TRIM7ACS Chemical Biology20240
28Structural Optimization of Oxaprozin for Selective Inverse Nurr1 AgonismJournal of Medicinal Chemistry00
29SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptorProceedings of the National Academy of Sciences of the United States of America20240